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a b s t r a c t
This paper aimed to clarify whether maternal inhalation of engineered nanoparticles (NP) may consti-
tute a hazard to pregnancy and fetal development, primarily based on experimental animal studies of
NP and air pollution particles. Overall, it is plausible that NP may translocate from the respiratory tract
to the placenta and fetus, but also that adverse effects may occur secondarily to maternal inﬂamma-
tory responses. The limited database describes several organ systems in the offspring to be potentially
sensitive to maternal inhalation of particles, but large uncertainties exist about the implications for
embryo–fetal development and health later in life. Clearly, the potential for hazard remains to be char-
acterized. Considering the increased production and application of nanomaterials and related consumer
products a testing strategy for NP should be established. Due to large gaps in data, signiﬁcant amounts
of groundwork are warranted for a testing strategy to be established on a sound scientiﬁc basis.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: Au, gold; Ag, silver; Cd, cadmium; CdTe, quantum dots coated with mercaptopropionic coating; CNS, cerebral nervous system; CNT, carbon nanotubes;
DA, dopamine; DE, diesel exhaust; DEP, diesel exhaust particles; DSP, daily sperm production; ECHA, European Chemicals Agency; eNOS, endothelial nitric oxide synthase;
ESTR, expanded simple tandem repeat; EU, European Union; FDA, Food and Drug Administration; GD, gestational day; GI, gastrointestinal; IL, interleukin; IV, intravenous;
MWCNT, multiwalled carbon nanotubes; NCTR, National Center for Toxicological Research; NIOSH, National Institute of Occupational Safety and Health; NM, nanomaterials;
NP, nanoparticles; OECD, Organisation for Economic Co-operation andDevelopment; PAH, polycyclic aromatic hydrocarbon; PEG, polyethyleneglycol; PM, particulatematter;
QDs, quantum dots; REACH, Registration, Evaluation and Authorisation of Chemicals; ROS, reactive oxygen species; Se, selenium; SO2, sulfur dioxide; SWCNT, singlewalled
carbon nanotubes; TEM, transmission electron microscopy; TiO2, titanium dioxide; ZnO, zinc oxide.
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1. Introduction
Nanotechnologies are among the fastest growing researchareas,
with promises of immense beneﬁts within many imaginable appli-
cations and industries, from health care to crop protection and
consumer products. A large number of nano-containing products
are already available and their global market is expected to exceed
several billion euros annually [1].
Increasing implementation of nano-based applications
enhances the likelihood of human exposure to the products
of nanotechnology and to nanoparticles (NP) themselves. This has
led to concerns about the ensuing potential risks to human health.
Of the many types of nanomaterials (NM), mainly the nano-sized
particles are suggested to pose a risk to humans. Engineered NMs
are intentionally designed and manufactured materials having
novel properties due to their nanoscale size in one or more dimen-
sions [2]. Engineering of nanoparticles provides NM with new
properties borne from the ability to design and control the atomic
structure, shape and surfaces (e.g., by use of coatings). Thus, the
physical and chemical properties of NMs may be fundamentally
different from that of their larger sized counterparts (generally
designated the bulk material). These same novel properties that
confer the desired material attributes for functional applications,
also fuel an expectation that the biological effects of NMs will
be different from those of the corresponding bulk material (and
perhaps even be more severe) [1]. It follows that the toxicological
properties may change in the aftermath of nano-engineering,
and that this may limit or even prevent the extrapolation of
bulk toxicological evaluations to NP of the same material, by
default.
It is broadly accepted that the fetus may be more sensitive to
chemical exposures than the adult organism [3]. Still, the database
on developmental toxicity of engineered NP is to date very limited
and remains insufﬁcient as a basis for risk assessment for pregnant
women and their children [4,5]. Furthermore, it is a prevalent con-
ception that as long as translocation of NMs from the port of entry
to the fetus is not indicated, fetal effects are considered unlikely [6].
In the occupational setting, and for many consumer products with
sprayapplications, inhalationwill be theprimary routeof exposure,
leading to deposition of particles in the lung. For particles to reach
the fetus, they need ﬁrst to translocate at the portal of entry, in this
case from the lung to the systemic circulation, and then to traverse
the additional barrier of the placenta [7]. However, particles may
notneed to reach the fetus toaffectdevelopment [8].Manyparticles
elicit inﬂammation and oxidative stress in the lungs [9–11]. Specif-
ically, during pregnancy, inﬂammation and oxidative stress induce
perturbations that have been shown to have detrimental and long-
lasting consequences for fetal development [12,13]. Furthermore,
inﬂammatorymediators are biologically activemolecules thatmay
trigger a range of responses in the tissues they reach. Inﬂammation
elicited in the lung may potentially alter neuroendocrine regula-
tion ofmaternal hormonal systems [14]. Fetal development ofmost
organs depends on tight hormonal control for optimal function in
the life after birth. Disruption of the maternal hormonal balance
during pregnancy may therefore have consequences for fetal and
postnatal development [15].
The lack of knowledge and attention to this area is all the more
alarming as the few published studies within this ﬁeld do actually
indicate that maternal exposure to NMs may be able to adversely
affect pregnancy, interfere with fetal development, and have con-
sequences for the offspring later in life (reviewed in [4,8,16]). That
potential developmental toxicityhas received little attentionseems
particularly odd in the view of emerging recognition of health
effects by exposure to ambient air pollution and the role that ultra-
ﬁne particles (i.e., particles with dimensions toward the nanoscale)
may play [17–20].
To summarize the state of knowledge and provide a basis for
risk assessment of airborne NP in the work environment and in
consumer products, this review aims to:
1. Clarify whether maternal inhalation of engineered NP may con-
stitute a hazard to pregnancy and development of the fetus.
2. Identify fetal organ systems that might be sensitive to mater-
nal inhalation exposure and therefore warrant further scrutiny,
based on experimental studies.
3. Outline recommendations for future testing strategies.
To achieve these aims, the reviewwill ﬁrst describe the evidence
for developmental toxicity for airborne NP. This information will
subsequently be combined with data from developmental toxicity
studies of NP using other routes of exposure, of ambient air pollu-
tion using total inhalable particulate matter as well as combustion
derived particles from diesel engine exhaust, as well as data from
epidemiological studies of ambient, particulate air pollution.
2. Developmental toxicity testing requirements for
nanomaterials
The European Commission recommended in 2011 that nano-
materials were deﬁned as a natural, incidental or manufactured
material where more than 50% of the particles had one or more
dimensions in the size range of 1–100nm [21]. For regulatory
toxicity testing, NM are currently evaluated similarly to the cor-
responding bulk chemical. The European Union (EU) states that the
current risk assessmentmethods are applicable for risk assessment
of NM, even if work on particular aspects of risk assessment is still
required. Nanomaterials are therefore regulated by the EU chemi-
cal safety regulation for the Registration, Evaluation, Authorization
and restriction of Chemicals (REACH) and the regulation for Clas-
siﬁcation, Labelling & Packaging (CLP). Thus, NM are deﬁned as a
“chemical substance” in both regulations and general obligations
for NM are similar to those for any other substance. Although the
European Commission considers that REACH sets the best possi-
ble framework for the risk management of NM when they occur as
substances or mixtures, more speciﬁc requirements for NM within
the framework probably prove necessary. The Commission also
foresees an impact assessment of relevant regulatory options, in
particular possible amendments of the REACH Annexes, to ensure
further clarity onhownanomaterials should be addressed and their
safety demonstrated in registration dossiers [22].
In Europe, testing of reproductive and developmental toxicity
of NM is therefore triggered in REACH when the chemical under
consideration has a production volume of 10 tons per year or more,
irrespective of its content of nanosized particles [23]. The REACH
Implementation Projects on Nanomaterials (RIP-oN-2) identiﬁed
reproductive toxicity as an endpoint for which “no important dif-
ferences between NM and non-NM are suspected in terms of the
applicability of the standard test guideline methods, but for which
an insufﬁcient evidence basis exists towarrant acknowledgment in
the guidance” [24,25]. Further research and development was con-
sidered required, in particular with regard to the value of in vitro
testing by the embryonic stem cell test, the micromass embryotox-
icity assay, and the whole rat embryo culture. For repeated dose
toxicity, it was recommended to include inhalation as a route of
exposure and to combine this study with a reproductive toxicity
screening study, e.g., the OECD testing guideline 422 [26], which is
also recommendedbyREACHat the tonnage level of 10 tons/year or
more for conventional chemicals. Furthermore, the RIP-oN2 report
stated that the use of in silico approaches such as (Q)SAR, group-
ings and read across for reproductive and developmental toxicity
arenot sufﬁciently developed forNM[24]. These recommendations
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Table 1
OECD guidelines for toxicity testing of developmental toxicity.
OECD guideline
number
Brief description
OECD 421 Reproduction/Developmental Toxicity Screening Test
OECD 422 Combined Repeated Dose Toxicity Study with the
Reproduction/Developmental Toxicity Screening Test
OECD 414 Prenatal Development Toxicity Study
OECD 416 Two-Generation Reproduction Toxicity
OECD 443 Extended One Generation Reproductive Toxicity Study
OECD 426 Developmental Neurotoxicity Study. This test is
harmonized with the US-EPA developmental neurotoxicity
guideline but includes a number of reﬁnements, such as a
longer postnatal exposure period
have been reproduced by the European Chemicals Agency (ECHA)
in their Guidance on information requirements and chemical safety
assessment for NM [25].
In the USA, the National Institute of Occupational Health and
Safety (NIOSH) recommends investigation of the potential for
developmental and reproductive effects by NM, in the National
Occupational Research Agenda by NIOSH’s Reproductive Health
Research Team. This is because it is theoretically possible that NP
may cross the placenta [27]. The regulatory testing requirements
of the US Food and Drug Administration (FDA) vary between the
product-categories that are regulated by the Agency. In 2014, the
FDA issued a number of guidance documents for industry, for safety
of NM in cosmetic products and use of NM in food for animals
[28]. Similar to the EU, the FDA generally considers the current
framework for safety assessment of chemicals sufﬁciently robust
and ﬂexible to cover NM. Nevertheless, one of the focal points of
FDA’s nanotechnology regulatory science research portfolio is the
adequacy of current testing approaches for assessment of safety,
effectiveness, and quality of products containing NM. Furthermore,
regulatory science research on nanotechnology in FDA’s National
Center for Toxicological Research (NCTR) aims to develop guide-
lines for the safe and effective use of NM in drugs, devices, foods,
cosmetics, anddietary components. It is not statedwhether speciﬁc
emphasis is placed on reproductive and developmental toxicity
[29].
Generally, international regulatory risk assessment frameworks
for industrial chemicals, pesticides, and biocides make use of OECD
guidelines for toxicity testing. The following testing guidelines for
developmental and reproductive toxicity testing are accepted as
test guidelines for use in the REACH framework (Table 1).
The OECD’s Working Party on Manufactured Nanomaterials
(WPMN) was established in 2006 and currently evaluates, and
wherenecessarymodiﬁes, existingguidelines for their applicability
to testing of NM, such as guidance on genotoxicity testing [30]. To
our knowledge, there are no speciﬁc activities on evaluating guide-
lines for testingof developmental and reproductive toxicity relative
to testing of NM.
In short, the existing regulatory testing requirements and
guidelines for developmental and reproductive toxicity testing
developed for chemical safety assessment are generally assumed
to be adequate for NM. The limited availability of data to sup-
port this assumption is, however, recognized. A recent gap analysis
undertaken as part of the ITS-NANO EU Framework 7 project on
the hazard of NM clearly highlighted the lack of information on
potential reproductive and developmental effects of NM [31]. Fur-
thermore, the project recommended investigation into the value
of some alternative tests for their putative application as screening
toolsorevenaspartial replacements for invivodevelopmental tests
in the testing of NM. An interesting point for consideration is that
grouping and read-across approaches under REACH are extremely
complex and generally considered insufﬁciently developed for NM
[32]. This implies that each and every variation of a nanomate-
rial should be evaluated separately with regard to their potential
reproductiveanddevelopmental effects, potentially resulting in the
requirement of numerous animal studies. In view of efﬁciency and
cost, and since reproductive and developmental studies already are
responsible for the majority of animal use for regulatory safety
testing for REACH [33], there is a clear need for development of
alternative testing strategies.
3. Toxicokinetics of maternal NM exposure relative to fetal
effects
A key issue in assessment of potential risks for developmen-
tal toxicity by NMs is the possibility for fetal exposure, due to
migration of particles into the uterus and the fetus. To affect the
fetus directly, the nanomaterial should ﬁrst become systemically
available and subsequently cross the placenta, unless particles are
already present in maternal tissues upon implantation or exposure
takes place early in pregnancy. Indirect effectsmay however be rel-
evant formaternal inhalation exposure, andmay to somedegree be
independent of the systemic availability, as will be discussed later.
3.1. Overall toxicokinetic pattern of inhaled particles
In the lung, uptake of particles occurs in the alveoli and depends
on the deposition of the particles. Particles with a diameter from 1
to 100nm show a much higher fraction of deposition in the pul-
monary region of the lung compared to larger particles [34,35].
For particulates, uptake into the systemic circulation is limited and
often amounts to less than a few percent of the total dose for most
routes of exposure [36,37]. This challenges study of transfer across
ﬁrst the lung barrier and secondly the placenta, as most methods
for detection are not able to detect and quantify small amounts
of particles in the tissue. This obviously hampers detection of a
slight transfer of particles into small amounts of tissue, as in the
fetus. The limit of detection for a commonly utilized measurement
technique of (metal) oxide NP, Inductively Coupled Plasma-Mass
Spectroscopy (ICP-MS), is in the order of 50ng/g tissue for TiO2
NP [38]. However, this may be relatively high compared to the
limited nanoparticle translocation across the lung membrane and
thus the minute amounts that may potentially reach the tissues of
both mother and/or fetus. Studies of tissue distribution and pla-
cental transfer have therefore mainly used the intravenous route
(IV) of administration [39–41] rather than inhalation exposure.
Intravenous administration furthermore allows for control of the
systemically available dose thus easing identiﬁcation of potential
target organs as well as their relative importance.
It must be taken into account that results may not be directly
extrapolated from IV administration to inhalation exposure. This
is because the systemic distribution pattern may depend on the
route of administration, as had been shown for a comparison of
IV versus intratracheal (deposition directly in the lung) admin-
istration of gold-NP [36,42,43]. This is probably because NP are
spontaneously coated with a range of different proteins when they
come into contactwith biologicalmedia; this is commonly referred
to as the “protein corona” [44,45]. As different protein coronaemay
arise when particles come into contact with bronchioalveolar ﬂuid
compared to plasma, differences in coronal composition relative
to the route of exposure might determine the overall distribution
patterns [43].
The surface composition of NP has a tremendous inﬂuence
on their behavior in vivo. PEGylation (covalent attachment of
polyethylene glycol polymer chains to the NP) is known to increase
the circulation time of NP in blood [46]. The surface composition
has also been found to affect accumulation of Au NP in fetuses of
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Fig. 1. Schematic representation of the anatomical characteristics of the different types of placentation inmammals. (A) Pigs and (B) Ruminants (sheep): the placenta is either
diffuse (A) or cotyledonary (B), i.e., organized into 70–100 separate entities named placentomes. There is no or very little trophoblastic invasion, respectively. Materno–fetal
exchange occurs through 6 cellular layers (maternal endothelium, mesenchyme and epithelium, trophoblast, mesenchyme and fetal vascular endothelium). (C) Primates,
rodents and lagomorphs (rabbits): the placenta invades the endometrium and destroys the maternal endothelium, thereby creating lacunae where the trophoblast is in direct
contact with the maternal blood. In mice, the trophoblast consists of three cell layers (hemotrichorial placentation) whereas only two trophoblastic cell layers persist at term
in primates and lagomorphs (syncytiotrophoblast and cytotrophoblast, the latter being discontinuous in late gestation; hemodichorial placenta). AC: amniotic cavity; AL:
allantoic cavity; P: placenta; U: uterus; UC: umbilical cord; YS: yolk sac.
mice. Thus, NP accumulation in the fetal tissues was observed prior
to gestation day (GD) 11.5 after intravenous injection to the dams
of gold NP (Au-NP) coated with ferritin, citrate or PEG in a saline
solution. A much larger transfer of ferritin-coated and PEGylated
NP compared to citrate-coated NP was observed, demonstrating
the importance of surface modiﬁcations. Although no NM were
found in the fetus after 11.5 days of gestation, the accumulation
of Au-NP in the extra-embryonic tissues increased substantially
thereafter [47]. The study indicates the presence of a time window
for nanoparticle placental transfer of 13nm Au-NP between GD 9.5
andGD11.5 that coincideswithmaturation of themurine placental
blood supply and barrier function of the placenta at around E10.
After IV administration of NP to adult animals, most particles
end up in liver and spleen. Both organs belong to the mono-
nuclear phagocytic system which has a major function in removing
foreign agents from the circulation. Very small NP may have a
more widespread tissue distribution than larger NP as was demon-
strated for Au-NP. The quantity of particles in other organs typically
account for a relatively low (0.1–0.2%) percentage of the injected
dose expressed as mass, although in absolute terms the number of
particles may be quite high (1010 per gram tissue) [39].
The evidence for widespread organ distribution of NP follow-
ing various routes of exposure seems limited. It can, however, not
be excluded that NP reach the uterus. Indeed, low levels of Au-
NPs (<0.2% of the administered dose in mass) were observed in
the uterus after both intratracheal and intravenous administration
of 1.4nm and 18nm Au-NPs [43]. Endocrine, vascular, inﬂamma-
tory or oxidative stress may impair the placental barrier function,
thus indirectly allowing more placental passage and induction of
adverse fetal effects.
3.2. Transplacental transfer
Placentation differs between species. Thus, in order to compare
available data on transplacental transfer of NP to the fetus, it is
necessary to understand the anatomical and physiological differ-
ences in placentation between humans and the model animal
species most commonly used to study developmental toxicology.
The placenta constitutes the complex interface between the
inner mucous membrane of the uterus (endometrium) and the
fetus, and ensures feto-maternal exchanges, but also has endocrine
and immunological functions. It is formed after implantation of
the conceptus, from the outer cell layer of the blastocyst (the tro-
phoblast) and is therefore of embryonic origin [48]. Various forms
of placentation are found in mammals (Fig. 1). Their differences
with respect to morphology, cellular organization and structural
separation of maternal and fetal blood may deeply affect transpla-
cental transfer of NM between model species [49,50]. Placental
structure and endocrine function evolve throughout gestation [51].
Furthermore, placental permeability to NM depends on the ges-
tational stage. Human placentation is hemochorial, denoting that
the trophoblast is in direct contact with the maternal blood.
At GD 21, the human trophoblast starts formation of villi that
invade deeply into the uterine wall to reach the maternal arter-
ies (Fig. 2). Direct contact with maternal blood occurs at the end of
the ﬁrst trimester, when trophoblastic plugs in the spiral arteries
are destroyed enabling maternal blood to ﬂow into the intervil-
lous chamber (reviewed in [52]). Primates, rodents and lagomorphs
(rabbits) also possess a hemochorial placenta. In themurinemodel,
trophoblastic invasion starts on GD 13 and completes at GD 15–18,
i.e., only a fewdays before birth onGD19–20. Thus, invasion is very
limited compared to humans [53]. In rats, invasion occurs between
15 and 18 days of pregnancy and is far more similar to the human
situation [54]. Other animal species, such as the sheep and pig,
possess an epitheliochorial placenta,where the placenta is apposed
to the maternal endometrium, with no trophoblastic invasion or
fusion of the 6 maternal and fetal membranes, although there are
extensive increases in interdigitation and thinning of the 6 mater-
nal and fetal cell layers during the course of gestation [49,50,52]
Fig. 1. It is apparent that the susceptibility to developmental effects
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Fig. 2. Schematic representation of the anatomical and cellular structure of the human placenta. (A) Anchored fetal villi showing the extravillous trophoblast reaching the
uterine spiral artery to form plugs in the ﬁrst trimester. The extravillous trophoblast lines and remodels the uterine spiral artery to allow free ﬂow of maternal blood into the
intervillous chamber [193]. (B) Transversal section of the fetal villi illustrating the hemodichorial structure of the human placenta where only two layers (syncytiotrophoblast
and the cytotrophoblast) separate maternal and fetal blood in the ﬁrst and (C) third trimester, where even the cytotrophoblast becomes discontinuous. CT: cytotrophoblast;
eEVCT: endovascular extravillous cytotrophoblast; DC: decidual cells; FV: fetal vessel; GC: Giant cells; iEVCT: invasive extravillous cytotrophoblast; IC: intervillous chamber;
M: mesenchyme; MSA: maternal spiral artery; pEVCT: proliferative extravillous cytotrophoblast; ST: Syncytiotrophoblast; UV: uterine vein; VCT: villous cytotrophoblast.
of inhaled NMs may change according to the gestational time of
exposure as both the embryo and the placenta undergo striking
anatomical and functional changes during pregnancy. Placental
permeability increases as gestation progresses. In this respect, bio-
chemicalmediators released into thematernal systemic circulation
may reach and damage the embryo at some stages of pregnancy,
but not at others [55].
3.2.1. In vitro models of the placenta
These are simpliﬁed in vitro cell culturemodels that can be used
in the study of transplacental transfer of NP. One of these is the
in vitro Transwell® insert model in which a membrane separates
two liquid compartments. Cells can be grown on both sides of the
membrane (e.g., epithelial andendothelial cells tomimic bloodves-
sels). Transport via the cells and membrane can be measured by
adding the substrate in the top compartment and measure pas-
sage to the other low compartment. The transport of particles over
the in vitro Transwell® insert model seeded with a trophoblas-
tic cell line was demonstrated to be size-dependent, showing a
higher transport rate for 50nm compared to 100nm ﬂuorescent
polystyrene NP over a period of 24hours (3.5% and 0.6%, respec-
tively) [56]. For poly-l-lactide-co-glycolic acid NP used as a drug
carrier for dexamethasone, a size-dependent crossing of the pla-
cental Transwell membrane model was also shown for 146nm
compared to 232nm particles [57].
3.2.2. Human placental perfusion models
Further information on placental transfer of NP may be gained
from the human placental perfusion model. The model mimics the
maternal and fetal blood circulation in the placenta by perfusing
a single cotyledon, excised from the placenta ex vivo. When parti-
cles are added to theperfusate at thematernal sideof the cotyledon,
measurement of the particular particle in the fetal perfusate allows
for study of transfer across the placenta. For 25nm and 50nm silica
NP, the transport into the fetal compartment in the humanplacenta
model was 4.2% and 4.6% of the internal maternal concentration,
respectively [58]. A substantial decrease in NP concentration was
noted in the maternal perfusate without a corresponding increase
in the fetal perfusate, indicating that NPs accumulated in the pla-
cental tissue. Fluorescent polystyrene beads of a diameter up to
240nm at a concentration of 25g/mL in ﬂuid on the maternal
compartment could cross the placental barrier almostwithout hin-
drance [59].
3.2.3. Animal models
Animals allow for study of placental transfer in vivo, in intact
biological systems. As indicated above, the low uptake from the
lung and limited transfer across the placenta combined with too
high limits of detection restrains the determination of NP in fetal
tissues. Therefore, most studies of placental transfer have applied
the IV route of administration rather than inhalation, usually fol-
lowing a single IV injection of the dam. By varying the day of
administration relative to the conception the changes in parti-
cle transfer during gestation can be evaluated. In pregnant rats,
the intravenous administration of 14C(C60) fullerenes resulted in
transfer into the placenta (2.21% of the injected dose) and fetuses
(0.87% of the injected dose) [60].When administered IV to lactating
dams on postnatal day (PND) 9, the presence of 14C in the GI-
tract and liver of the pups (2.7–4.3% and 0.05–0.06% of the injected
dose, respectively) demonstrated that 14C(C60) fullerenes reached
the pups via the milk. 99Technecium-labeled multi-walled carbon
nanotubes (MWCNT) were intravenously injected into pregnant
mice at approximately GD 17 [61]. After 24h, the highest quantity
of MWCNT was observed in the lung followed by the liver, in both
the mother and fetuses. In the fetus the quantity of 99Technecium
was approximately 1% of the injected dose.
In pregnantmice, a single intravenous injectionof quantumdots
consisting of a cadmium–tellurium (CdTe) core with an outer layer
ofmercaptopropionic acid betweenGD 20 and 22, led to a size- and
dose-dependent accumulation, measured as Cd, in the pups indi-
cating placental transfer of 0.23–0.61% of the injected dose, with
higher dosages showing a reduced actual transfer to the fetuses
[62]. Inhalation of 11–15nm cadmium oxide NP from GD 4.5 to day
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Fig. 3. Mechanistic pathways in developmental toxicity of NP. NP may potentially affect embryonic/fetal development via direct as well as indirect mechanisms. Indirect
effects may arise if inhaled NP deposit in the maternal alveoli and here generate reactive oxygen species, in amounts that results in oxidative stress, and inﬂammation. The
inﬂamed lung tissue may then release inﬂammatory mediators, such as cytokines and acute phase proteins, to the blood stream, to be transported to organs and tissues with
relevance for pregnancy and development (uterus, placenta, fetus), as well as maternal neuro-endocrine and immune circuits. Here the biologically active mediators may
trigger a range of responses which in turn may interfere with development. If NP translocate from the alveoli to the maternal blood stream, they may reach the placenta
and be taken by the placental cells. Particle induced generation of ROS and inﬂammation has been proposed to interfere with placental vascularization. If NP passes the
placenta, they may exert toxicity directly through generation of ROS and inﬂammation in fetal tissue. Especially tubular NP have furthermore been proposed to interfere
directly with cellular and extracellular constituents and thereby alter vital cellular processes. Finally, toxicity may occur due to the action of released chemical constituents
or functionalizations of the NP or contaminants, such as metal catalysts used during manufacture. These may increase generation of ROS, and affect the placenta and the
fetus.
17.5 in mice increased Cd in both the uterus and placenta, but no
Cd could be detected in the fetuses [63].
Two intravenous injections at GD 16 and 17, each of 0.4mg of
70nm silica or 35nm titanium dioxide (TiO2) NPs led to the pres-
ence of these particles in the placenta, the fetal liver and fetal brain,
as evidenced by transmission electron microscopy [64]. Finally,
20–50nm 0.01% colloidal Au-NM solutions were injected intra-
venously into mice at GD 16 and 17. Au-NM was found in the
exposed placentas at GD 18 alongside an apparent increase in
placental endocytosis compared to that of control placentas. No co-
localization of NMand endocytosis vesicleswas however observed,
suggesting that NP were translocated by another mechanism, e.g.,
passive diffusion. In the fetal organs no detectable levels of gold
were found [65]. For iron oxide NPs (Fe2O3-NP), Fe content in the
placenta and fetal liver increased after intraperitoneal injections of
pregnant mice at GD 9–16 with positively but not with negatively
charged NP [66].
In conclusion, translocation and organ wide distribution were
demonstrated to occur after inhalation and IV administration ofNP.
As would be expected, the observed systemic availability is much
lower after inhalation than after intravenous administration. In
addition, smallerNPdopresent a greater potential for translocation
from the lung to the systemic circulation and therefore for subse-
quent distribution to, e.g., the uterus. When systemically available,
placental translocation of particles into the fetus has been demon-
strated for various types of NP. Data from ex vivo [58,59,67] and
in vitro cellular barrier models of the placenta all indicate that pla-
cental transport of NP across the placenta, i.e., from thematernal to
the fetal compartment is possible [56,57,68,69]. Furthermore, there
was good agreement between ﬁndings from the in vitro cell system
and the humanplacentamodel [69]. Animal studies using exposure
via IV injection indicate that transplacental passage of NM depends
on particle characteristics (size, surface coating), route, dose and
duration of exposure, as well as on the animal model and timing in
pregnancy. The mechanisms underlying translocation of particles
across the placenta remains to be elucidated. Of note, a recent study
showed a strongly increased transfer of gold NP across the placenta
in mice with intrauterine inﬂammation in comparison to healthy
mice [70]. Whether chronic, low-grade inﬂammation, such as that
associated with asthma or obesity, also increases the translocation
across the placenta remains to be elucidated.
4. Potential mechanisms in developmental toxicity of
inhaled NM
Developmental toxicity may potentially be induced by inhaled
engineered NMs through several pathways which may interfere
directly or indirectly with the course of pregnancy and fetal devel-
opment. Importantly, the mechanisms are not mutually exclusive
(Fig. 3).
4.1. Particles may generate reactive oxygen species and
inﬂammation
When nano-sized particles are inhaled they may deposit in the
airways and lungs, including the alveoli. Many NM are charac-
terized by a high surface reactivity and thus demonstrate a high
inherent potential for induction of inﬂammation and generation of
reactive oxygen species (ROS) at the site of deposition [9,11]. ROS
generation is generally considered a major causative factor in the
toxicity of NMs. This may occur due to properties directly related
to the NM, e.g., via surface-mediated reactions, or through acti-
vation of oxidative enzymatic pathways in the cells (reviewed in
[71]). ROS are usually too unstable to travel far beyond the place
of formation [12], but if the balance between oxidant and antioxi-
dant mechanisms is skewed, oxidative stress may arise and induce
or exacerbate particle-induced inﬂammation. Neither the parti-
cles nor the inﬂammatory condition need to be conﬁned to the
lungs. Particles may translocate and inﬂammatory mediators may
be released into the systemic circulation [72,73] and transported
to organs of importance for pregnancy and fetal development, e.g.,
the maternal neuro-endocrine circuits, placenta, uterus, and fetus.
It is of interest, that systemically available NP may be taken up by
placental cells and interfere indirectly with fetal development by
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inducing oxidative stress and inﬂammation therein. Of note, pla-
cental cells contain toll like receptors, that has been shown to be
involved in the particle induced inﬂammatory response in the air-
ways [74,75]. Two studies show that exposure of pregnant rodents
to CNTs may lead to fetal damage, associated production of ROS
and histopathological damage to the placenta [61,76]. Yet another
study found exposure to TiO2 concurrent with oxidative damage in
the placenta [64].
4.2. Direct effects of particles on fetal development
Particles that are able to traverse ﬁrst the pulmonary and subse-
quently the placental barrier may reach the fetal entity, and among
others confer their oxidative and inﬂammatory action directly in
fetal tissues. Furthermore, the size and shape of some NMs make
them potentially able to interfere with cell division and cell align-
ment, crucial events in thedevelopingembryo.As anexample, CNTs
may interfere with cell division because of their similarity to the
cellular microtubules which form the mitotic spindle (Reviewed in
[71]).
4.3. Indirect effects due to maternal inﬂammatory response
When exposure to chemicals occurs in adulthood, toxicological
effects may be temporary. During pregnancy, chemical exposures
may alter the developmental trajectory of the fetus and perma-
nently shape the physiology and function of the child. The induced
alterations are thought to occur as an adaptation by the fetus to
an adverse intrauterine environment, to prepare the fetus for the
conditions waiting in postnatal life, so-called fetal programming
[77], probably via epigenetic mechanisms [78,79]. If this develop-
mental programming does not match the conditions in postnatal
life, physiological dysregulation may arise and affect health later in
life [80]. Taking into account that low grade chronic inﬂammation
is a leading mechanism of several disorders in adult humans [81],
it might not be surprising that maternal inﬂammation (along with
oxidative stress) may interfere with fetal development and alter
organ function in the offspring later in life [8,12,13,82–84]. This
couldbeviewedasanaspectof fetal adaptation to the inﬂammatory
environment of the mother.
Systemic inﬂammation has been reported after pulmonary
exposure to NM, and is generally more pronounced than that
elicited by larger particles in the bulk form [85]. This may be
related to the relatively larger surface contact area of NP, and to
the release of additional biological mediators from other internal
organs should a quantity of NPs reach the systemic circulation.
One study provides some evidence that NP-induced pregnancy
complications may originate from particle induced inﬂammation.
Thus, pregnant mice were exposed to 70nm silica NP by the
IV route. Exposure increased the incidence of pregnancy com-
plications. In the placenta, exposure increased the inﬁltration of
inﬂammatory cells, especially neutrophil granulocytes, as well as
the level of several inﬂammatory cytokines and upregulation of
inﬂammasome components. Forced expression of interleukin-10
(a cytokine with strong anti-inﬂammatory properties) prevented
pregnancy complications [86].
Evidence of an association between lung exposure to NM, sys-
temic inﬂammation and fetal abnormalities is however speculative,
as only a few, circumstantial, reports on MWCNT have addressed
this topic. Thus maternal lung exposure to MWCNT was associ-
ated with malformations but only at dose levels which increased
leukocyte counts in maternal peripheral blood (a marker of inﬂam-
mation). It might therefore be speculated that the presence of
inﬂammation at least have contributed to the observed increase in
malformation rate [87]. Another indirect link comes from observa-
tions of an imbalance in the secretionof progesterone andestradiol,
concomitantly with reduced fetal growth and survival [61]. Since
inﬂammatory cytokines may cause endocrine imbalance [88], it
might be hypothesized that MWCNT-induced release of cytokines
underlies the observed alterations in secretion of progesterone and
estradiol in gestation.
Although the relative contributionof the size and content of par-
ticles relative to other chemical constituents was not determined,
exposure of rats to urban air pollution with a high content of par-
ticles (PM2.5, 600g/m3) before and during pregnancy increased
the cytokine of interleukin 4 (IL-4) in the fetal part of the placenta,
indicating a placental inﬂammatory reaction [89].
In summary, although there is some evidence that local and
systemic inﬂammation induced by exposure to NM are associated
with fetal developmental abnormalities (which may or may not be
mediated by the placenta), there is a paucity of data showing that
this chain of events may occur after pulmonary exposure in preg-
nancy. Importantly, effects might occur in the absence of direct
contact of particles with fetal tissues. Thus, in a recent in vitro
study, a placental model was exposed to NMs, which were unable
to cross the placenta. DNA damage was induced in embryonic cells
placed directly below placenta. The genetic damage was found to
be perpetrated by a release of ATP into the extracellular space and
mitochondria-derived free radicals [90].
4.4. Toxicity mediated by chemicals associated with NM
Toxicity may also occur due to chemicals associated with NM.
These may originate from purposeful functionalization of NMs by
addition of chemical constituents, or from contaminants such as
metal catalysts used during manufacture. These may increase the
generation of ROS, and affect the placenta and the embryo/fetus. A
well-known example relates to the fetal toxicity caused by release
of cadmium from (CdSe)-quantum dots [91].
Overall, most data are generated in experimental animals
(mainly rodents) and suggest thatmaternallymediated effectsmay
predominate. This is not surprising, as only very small quantities of
NM will be able to cross the lung barrier [39,43]. Several indirect
pathwaysmaypotentially be involved inperturbationof pregnancy
and developmental toxicity.
5. Adverse effects of maternal airway exposure to
nanoparticles during pregnancy
The database on developmental toxicity of engineered NP fol-
lowing inhalation exposure is to date very limited. To achieve
our aims, the review will therefore ﬁrst describe the evidence
for developmental toxicity for airborne NP, supplemented with
data from studies using other routes of exposure. Some stud-
ies investigate effects in several organ systems, their design are
described in detail upon their ﬁrst appearance. Finally, we brieﬂy
summarize ﬁndings from studies of ambient air pollution and com-
bustion derived particles. In order to identify organ systems that
might be sensitive to maternal inhalation exposure and there-
fore warrant further scrutiny, ﬁndings on each organ system is
described individually. A separate section is allocated to the evi-
dence from epidemiological studies of ambient, particulate air
pollution.
5.1. Gestational and litter parameters
The limited data set on NM does not support adverse effects on
classical gestational and litter parameters in experimental animals
due tomaternal airwayexposure tomostNM.One studyofMWCNT
did however observe malformations after a single maternal instil-
lation of MWCNT during gestation. Also inhalation of cadmium NP
interferedwithmaternal and fetal growth. In comparison,maternal
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inhalation of DE and DEP are associated with effects on offspring
weight, at birth, in lactation, and even in adult offspring in several
studies.
Most of the studies conducted to evaluate the effects ofmaternal
airway exposure to NP on gestational and litter parameters involve
high dose ranges with end-gestational evaluation, as reported in
Table 2. In one maternal inhalation study, time mated mice were
exposed to 42mg/m3 TiO2 NM (UV-titan L181, Kemira, Finland)
for 1 hr/day on GD 8–18. The dose from 1h of exposure to
40mg TiO2/m3 corresponds to the 8-h time weighted average
(TWA) occupational exposure limit according to Danish Regula-
tions. The particles consisted ofmainly 21nmelongated rutile TiO2.
In the exposure atmosphere, 80% of the particles were between
40 and 200nm in diameter. Of the estimated inhaled dose of
840g of TiO2, approximately 30% reached and persisted in the
maternal lung tissue until weaning. The particles caused persis-
tent inﬂammation in the maternal airways, still present 3 weeks
after termination of exposure, as well as acute phase response
[9,73,92,93]. Exposure was not associated with effects on gesta-
tional or lactation parameters (maternal weight gain, gestation
length, litter size, sex distribution, birth and lactation weights,
implantations and loss thereof) [9]. The limitation of this study is
the single dose level.
Two other studies from the same laboratory addressed the
effects of maternal airway exposure to the 14nm carbon black
particle of Printex 90, using exposure by inhalation and intra-
tracheal instillation, respectively [10]. Printex 90 has been used
extensively as a model for the particulates in diesel emission, as it
contains less than1%organic and inorganic impurities. Time-mated
C57BL/6BomTac mice were exposed by inhalation to 42mg/m3
Printex 90 for 1h per day on GD 8–18. The daily dose was equiv-
alent to 12h of exposure at the Danish occupational exposure
level for carbon black (3.5mg carbon black/m3). In the exposure
atmosphere, the average particle size distribution was highly dom-
inated by sub-100nm NP, the most abundant size number being
approximately 40nm. The other study administered particles by
intratracheal instillation [10]. Time-mated mice were exposed four
times during gestation (on GD 7, 10, 15 and 18) to total doses of 11,
54 and 268g of Printex 90 (12.2, 2.5 and 0.5mg/kg), dispersed
in clean water. The zeta-size in the particle suspension averaged
approximately 140nm and the number size-distributions peaked
at 50–60nm. The highest dose level was calculated to correspond
to the lung deposition in the inhalation study described above [10].
In both studies, exposure induced inﬂammation and acute phase
response in the lungs of the females, but did not affect gestational
or lactationmeasures (assessedasdescribed forTiO2) [10,73,94,95].
Also MWCNT have been studied in mice, after maternal intra-
tracheal instillation of a single dose of 67g/mouse, followed the
day after by cohabitation with a male. The particle was the highly
bent NM-400 (Nanocyl, Belgium), 10nm in diameter and 295nm
in length. For instillation, MWCNTs were dispersed in nanopure
water with 2% mouse serum. No effects were observed on gesta-
tional and litter parameters [96]. Another study assessed the effect
of maternal instillation of the MWCNT-7, with an average diame-
ter of 100nm. One fourth of the particles were longer than 5m.
For instillation, the MWCNT was suspended in 2% sodium carboxyl
methyl celluloseandadministeredonce topregnantmiceonGD9at
100.8, 135.2, and 162.5g/mouse [87]. External and skeletal exam-
inations of fetuses for malformations were performed on GD 18.
MWCNT decreased maternal weight on GD 18 and fetal weight at
the highest dose level. The number of leukocytes in maternal blood
was increased at the highest dose levels. More dams had fetuses
with external and skeletal malformations at the two highest dose
levels.
Inhalation of 11–15nm cadmium oxide NP by pregnant mice
2.5h/day from GD 4.5 to day 17.5 (230g/m3) decreased the
incidence of implantation, interfered with maternal weight gain
and neonatal growth, altered placental weight, and decreased fetal
length [63].
Additional information can be obtained from studies of mater-
nal exposure to diesel exhaust (DE; reviewed in [19,20]). Most
studies in rodents are indicative of reduced postnatal growth
in offspring from exposed dams [19,97,98], although one study
demonstrated increased body weight at 10 weeks of age in the
in utero exposed mice [99]. Furthermore, paradoxical increases
in fetal weight at term after maternal exposure at various stages
of pregnancy have also observed in some [100–102] but not
other studies [99,103–105]. Preconceptional exposure may also be
important. In mice, exposure of dams during the 4 months before
mating, butnotduringpregnancy, didnot affect fertility of thedams
nor fetal growth. Although birth weight was slightly increased
in male offspring, subsequent reduction of postnatal growth was
observed in offspring of both sexes after weaning [106].
It is interesting that effects on maternal gestational weight gain
and offspring growth during gestation and lactation are found in
studies of DE and DEP as well as for NP containing Cd. This indi-
cates that the chemicals associated with the particles (Cd, PAHs)
rather than the particulate fraction may be responsible for these
effects. Thus, the embryotoxic potential of cadmium has been
widely demonstrated previously [62]. Chemicals associated with
diesel exhaust have been associated with endocrine disrupting
properties, i.e., to alter function(s) of the endocrine system and
consequently cause adverse health effects in the intact organism,
or its progeny [107–109]. According to the newly proposed “devel-
opmental obesogen hypothesis”, early exposure to some chemicals
may metabolically program the offspring and thus modulate off-
spring growth, in pre- as well as postnatal life [110]. This may in
some cases predispose individuals to increase fatmass and become
obese [111], whereas in other cases a suboptimal intrauterine envi-
ronment may restrict fetal growth. If followed by compensatory
body fat accumulation, overeating may increase susceptibility to
obesity in an environment with easy access to high-caloric food
[112]. It would be interesting tomore speciﬁcally address this topic
by comparing the effects on growth in mother and offspring fol-
lowing exposure to particles devoid of associated chemicals (e.g.,
Printex 90 carbon black), Printex 90 enriched with PAHs, and PAHs
alone, respectively.
5.2. Nervous system
Studies of behavior and brain histology in mice indicate that
maternal inhalation exposure to NP may affect the developing ner-
vous system. Findings in studies of DE and DEP provide additional
indications that the developing central nervous systemmaybe sen-
sitive todisruptionbyparticulate exposures, although these studies
do not delineate the relative contribution fromparticles, associated
chemicals and exhaust gases.
Various studies have assessed the effect of maternal pulmonary
exposure to NM (Table 3). Hougaard et al. addressed neurofunction
in offspring born to mice exposed by inhalation to 42mg/m3 nano-
sized TiO2 on GD8-18, 1h/day, as described in more detail above
[9,93]. Exposed offspring of both sexes exhibited altered activity
in the open ﬁeld test, characterized as an inclination to avoid the
central area of the maze. Female offspring exhibited enhanced
pre-pulse inhibition in the acoustic startle test. Cognitive function
assessed in the Morris water maze was not affected. A second
study from the same laboratory addressed maternal exposure
to carbon black (Printex 90) by intratracheal instillation four
times during gestation, at a total dose of 268g/animal. Female
offspring displayed a somewhat altered habituation pattern in
the open ﬁeld test. No effect was observed in the acoustic startle
test [94]. In a recent study ICR mice were intranasally instilled
126 K.S. Hougaard et al. / Reproductive Toxicology 56 (2015) 118–140
Table 2
Effects of maternal airway exposure to NP on gestational and litter parameters.
Type of NP Animal
species
(group size)
Particle size
(nm)
Mode of
airway
exposure
Air particle
concentra-
tion
Dose (total) or
hours/day
Exposure
period (GD)
Outcome(s) Ref.
TiO2
(UV-Titan
L181)
Mouse
(n=12–14)
20.6
(primary),
∼100
(aggregate)
Whole body
inhalation
42.4mg/m3 1h/day 8–18 Maternal
persistent
inﬂammation
in lung
No effect on
gestation or
lactation
[9]
Carbon black Mouse 14 (primary),
41
(aggregate)
Whole body
inhalation
42mg/m3 1h/day 8–18 No effect
effects on
gestation and
lactation
[10]
Carbon black Mouse 14 (primary),
50–60
(aggregate)
Intratracheal
instillation
11–268g/mouse 7, 10, 15, 18 No effect
effects on
gestation and
lactation
[10,94]
Cadmium
oxide
Mouse Inhalation 100
or
230g/m3
2.5h every other
day
or
2.5h/day
4.5–16.5 Daily
inhalation
altered
placental
weight,
decreased
fetal length
and delayed
neonatal
growth
[63]
MWCNT Mouse Length: 5m Intratracheal
instillation
3-5 mg/kg
(100.8–162.5g/mouse)
9 At G18
decrease of
maternal and
fetal weight
at highest
dose level
plus skeletal
malforma-
tions
[87]
MWCNT Mouse
(n=14)
Length: 295
Diameter: 10
Aspect ratio:
31
Intratracheal
instillation
– 67g/mouse 1 day
premating
No effect
effects on
gestation and
lactation
[96]
GD: gestation day.
with ultraﬁne carbon black particles on GD 5 and 9 at a total
dose of 190g/kg. Male offspring showed enlarged and increased
numbers of perivascular macrophages that are regulating the
inﬂammatory response in the CNS, as late as 12 weeks after birth.
Moreover, astrocytes in the proximity of these macrophages
displayed phenotypic changes similar to that observed in blood
vessel damage related to ischemia [113]. No effects on sponta-
neous activity and acoustic startle response were observed in
the offspring of mice preconceptionally exposed to intra-tracheal
instillation of MWCNTs (67g/animal), in spite of the presence of
long-lasting pulmonary inﬂammation in the dams [96]. The mere
presence of persistent pulmonary inﬂammation (and the related
systemic consequences) during gestation did therefore sufﬁce to
change function of the assessed domains in the offspring.
Additional information can be obtained from studies of mater-
nal exposure to ambient air pollution or resuspended particles in
aerosols (reviewed in [19,20]). Maternal gestational exposure to
DE (0.3–3mg/m3) at GD 2–16 induced extensive pathology such
as apoptosis and capillary stenosis and occlusion in the brain of
11 weeks old offspring [114] and decreased the number of Pur-
kinje cells in the cerebellum [115] in ICR mice. A similar exposure
regimen applied on GD 2–16 and again on PND 0–16 altered the
levels of mRNA encoding for proteins involved in reaction to chem-
ically induced stress (including oxidative stress) and endocrine
regulation in both sexes as measured during lactation [108].
Prenatal exposure to whole DE have been shown to reduce spon-
taneous motor activity, impair motor coordination and function
of monoaminergic systems in various brain regions, and induce
impulsive behavior [116–118]. DEP exposure (1000g/m3) during
pregnancy andnursing increased locomotor activity, self-grooming
in the presence of an unfamiliar mouse, and rearing behavior in the
adult male offspring [119]. Prenatal exposure to DE on GD 9–17
increased fetal brain cytokine response at GD 18 and reduced activ-
ity in male offspring. When exposed to a high fat diet males had
higher insulin levels and both sexes showed increased activation
of microglia within several brain regions [120]. Inhalation expo-
sure of female C57BL/6J mice from 7 weeks before conception until
GD 18 to nanoscale particulate matter (350g/m3) impaired the
in vitro differentiation of cerebral cortex neurons obtained from 1
day old offspring. Despite normal physical development, 8 months
old exposed males displayed decreased latency, frequency, and
duration of immobility in the tail suspension test, whereas exposed
female offspring behaved as controls [121].
At present, the number of studies on effects of exposure to NPs
during pregnancy on the nervous system is limited. The param-
eters that were investigated differ between the studies, making
it difﬁcult to draw conclusions on similarities and differences in
nervous system effects caused by the various materials. Further-
more, the experimental designs of the studies differ considerably
with respect to route, time and duration of exposure, ages of the
offspring at testing, etc. Thus, prenatal exposure to NPs, DE, and
DEP have been associated with effects on locomotor activity in the
offspring in a number of studies, but both increases and reduc-
tions have been reported, and in some cases only more speciﬁc
K.S. Hougaard et al. / Reproductive Toxicology 56 (2015) 118–140 127
Table 3
Effects of maternal airway exposure to NP on the nervous system of the offspring.
Type of NP Animal
species
(group size)
Particle size
(nm)
Mode of
airway
exposure
Air particle
concentra-
tion
Dose (total)
or hours/day
Exposure
period (GD)
Outcome(s) Ref.
TiO2 (UV-Titan
L181)
Mouse
(n=10–14)
20.6
(primary),
∼100
(aggregate)
Whole body
inhalation
42.4mg/m3 1h/day 8–18 Exposed offspring
avoided central
zone of open ﬁeld
Female offspring
displayed
enhanced prepulse
inhibition
Cognitive function
in Morris maze not
affected
[9]
Carbon black
(Printex 90)
Mouse
(n=17–24)
14 (primary),
50–60
(aggregate)
Intratracheal
instillation
– 0, 11, 54 or
268g/animal
7, 10, 15, 18 Female offspring
displayed altered
habituation pattern
in open ﬁeld
Acoustic startle and
prepulse inhibition
not affected
[94]
MWCNT Mouse
(n=14)
Length: 295
Diameter: 10
Aspect ratio:
31
Intratracheal
instillation
– 67g/animal 1 day
premating
No effect on
locomotor activity
and startle
response in males
[96]
Ultraﬁne
Carbon black
Mouse
(n=5)
14 (primary),
84.2
(agglomer-
ate)
Intranasal
deposition
– 190g/kg 5, 9 Male offspring
showed enlarged
and increased
numbers of
perivascular
macrophages and
nearby astrocytes
displayed
phenotypic
changes
[113]
GD: gestation day; PND: postnatal day.
measures has been affected, e.g., the propensity to enter the cen-
tral part of a maze. It is therefore not clear whether these apparent
similar or dissimilar effects can be attributed to the test material,
or even if absence of effects might be ascribed to differences in
the applied test designs. Further contributing to the complexity,
the studies of DE and DEP imply exposure to mixtures of various
particulate matters with dissimilar contents of associated chemi-
cals, and, in the case of DE, also gases thatmay differ in composition
between studies. Thismakes it difﬁcult to delineatewhether obser-
vationsmay be ascribed to particles or other chemical components.
Of note, the mere presence of persistent pulmonary inﬂammation
(and the related systemic consequences) does not seem to explain
the neurobehavioral effects observed for titanium dioxide and car-
bon black, since no neurological effects were observed in offspring
of mothers exposed to MWCNTs pre-conception, in spite of long-
lasting pulmonary inﬂammation.
5.3. Reproductive system
The literature, to date, provides some, limited evidence, that
NP may affect fetal development of the male reproductive system.
Reproductive function in female offspring has hardly been studied
and cannot be commented upon.
Anumberof studieshaveexaminedmaternallymediatedeffects
of NP exposure to the reproductive health of their male offspring,
using administration via the airways as well as other routes of
administration (Table 4. Pregnant mice were exposed to 14nm
carbon NPs during gestation following intratracheal administra-
tion of 0.2mg at GD 7 and 14. In the exposed offspring, partial
vacuolation of the seminiferous tubules, other testicular structural
changes and signiﬁcant reductions in daily spermproduction (DSP)
were observed [122]. Kyjovska and co-workers [123] examined
the impact on DSP in F1 and F2 male mouse offspring following
maternal inhalation of 42mg/m3 nanosized TiO2, 1h/day, on GD
8–18 [9,93] or intratracheal instillation of carbon black to a total
dose of 268g of Printex 90 divided between GD 7, 10, 15 and
18 [10] (both studies have been described in more detail above).
DSP was not statistically signiﬁcantly altered in the F1 genera-
tion for either exposure group, although TiO2 tended to reduce
sperm counts in the F1 offspring, with no observed effects car-
ried to the F2 generation. For carbon black, F2 offspring whose
fathers were prenatally exposed to NP showed a lowering of DSP,
whereas no effect was observed in F2 offspring from the exposed
F1 females. Neither exposure statistically signiﬁcantly affected the
time it took to deliver the ﬁrst litter, when the exposed F1male and
female offspring cohabited with unexposed partners [9,93,123].
One recent study extended the typical dosing regimen to exam-
ine the effects of preconception exposure. Female C57BL/6J mice
were intratracheally instilled with 67g MWCNT (NM 400) and
then bred the next day with an unexposed male. No changes in DSP
were reported in themaleoffspring.Notably, the lung inﬂammation
due to MCWNT exposure would have been expected to be present
throughout gestation [96]. Supplementary information is available
for the subcutaneous route. When 25–70nm TiO2 anatase NP were
administered four times between GD 3 and 14, particles accumu-
lated in offspring testis and affected DSP [124]. Overall, there is
some indication that NP are able to affect reproductive function in
the male offspring, but the pattern of effects differs between stud-
ies. This could well owe to the choice of route of administration,
dose and type of material.
Although prenatal exposure to TiO2 did not affect the time it
took the F1 females to deliver their ﬁrst litter when cohabiting
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Table 4
Effects of maternal airway exposure to NP on the reproductive system of the offspring.
Type of NP Animal species
(group size)
Particle size (nm) Mode of airway
exposure
Air particle
concentration
Dose (total) or
hours/day
Exposure period
(GD)
Outcome(s) Ref.
TiO2
(UV-Titan L181)
Mouse
(n=10–14)
20.6 (primary),
∼100 (aggregate)
Whole body
inhalation
42.4mg/m3 1h/day 8–18 When F1 male and
female offspring
were mated with
unexposed offspring,
there was no effect
on time to delivery of
the ﬁrst F2 litter
F1 males showed a
tendency toward
reduced sperm
counts, no effect in
F2 male offspring
from either the male
or female germline
F1 offspring gene
expression in liver
relating to retinoic
acid were changed in
newborn females
[9,93,123,149]
CdO Mouse
(n=8–19)
11nm at
100g/m3
15nm at
230g/m3
Nose-only
inhalation
100
or
230g/m3
2.5h every other
day
or
2.5h/day
4.5–16.5 No reports of
reproductive effect in
F1
[63]
Carbon black Mouse 14nm Intratracheal
instillation
0.2mg/mouse 7 and 14 Exposure to CB
affected F1 male
reproductive
function adversely,
with impact on DSP,
seminiferous tubules
and serum
testosterone
[122]
Carbon black
(Printex 90)
Mouse
(n=12–13)
14 (primary),
50–60
(aggregate)
Intratracheal
instillation
– 268g/mouse 7, 10, 15, 18 When F1 male and
female offspring
were mated with
unexposed offspring,
there was no effect
on time to delivery of
the ﬁrst F2 litter
No effect on DSP in
F1 males, but F2
males showed lower
sperm production,
when their F1 father
had been exposed in
utero (not their F1
mother)
[10,123,151]
MWCNT Mouse
(n=14)
Length: 295
Diameter: 10
Aspect ratio: 31
Intratracheal
instillation
– 67g/mouse 1 day premating No effect on DSP in
the offspring
[96]
GD: gestation day; PND: postnatal day; DSP: daily sperm production.
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Table 5
Studies investigating the relationship between nanoparticle exposure during pregnancy and biodistribution and toxicity in embryonic and extraembryonic tissues.
Type of NP Animal
species
Particle size
(nm)
Route of
exposure
Dose Exposure period
(GD)
Biodistribution to (method
of analysis)
Toxicity Ref.
Metal based NM
Gold Mouse 20, 50 IV 50g/mouse 16 and 17 Placenta
(ICP-MS)
NE [65]
Gold Mouse 3, 13, 32 IV 0.8mg/kg 17 Placenta
Fetus after LPS stimulus
(ICP-MS)
NE [70]
Gold Mouse 3, 13, 32 IV 0.9, 7.2mg/kg 5.5–15.5 Placenta
Fetus
Extraembryonic tissues
(ICP-MS)
None [47]
Gold Mouse 2, 40 IV 0.4mg/kg
(2nm)
1.9mg/kg
(40nm)
16–18 Maternal liver and spleen
Not placenta and fetus
(AMG)
NE [163]
Silver Mouse 50 IV 35 or
66g/mouse
7,8,9 Placenta (0.2%)
Yolk sac (0.3%)
Embryos (0.008%)
(ICP-MS, TEM, EDS)
None [155]
TiO2 Mouse 217 IV 0.8mg/mouse 16, 17 Placenta, fetal liver and
brain
(TEM)
Reduced fetal size [64]
SiO2 Mouse 65 IV 0.8mg/mouse 16, 17 Placenta, fetal liver and
brain
(TEM, WBF)
Placental dysfunctions
Increased fetal resorptions
Reduced fetal size
[64]
CdTe/CdS QD Mouse 1.67–4.2 IV 20–125g/mouse 1–5 days before
delivery
Fetuses and pups
(ICP-AES)
Reduced pup survival at
high concentration
[62]
Silver Mouse 20 Oral 10, 100,
1000mg/kg
9 Fetal liver
(TEM)
Reduced viability of
offspring
[159]
Silver Rat 35 Oral 1.69mg/kg 20 Fetus (0.003–0.03%)
(Scintillation counter)
NE [191]
Silver Rat 8 Oral 62.5, 125,
250mg/kg
52 days
(including
pregnancy)
NE None [162]
ZnO Rat <100 Oral 500mg/kg 39 days
(including
pregnancy)
Liver and kidney of pups
(ICP-MS)
Reduced number of
born/live pups, decreased
body weights of pups and
increased fetal resorption
[127]
TiO2 rutile Mouse 50 (472) Oral 10, 100,
1000mg/kg
9 NE Morphological defects
Reduced viability
[159]
TiO2 anatase Mouse 25–70 S.C. 100g/mouse 3,7,10,14 Testis and brain of
offspring
(FE-SEM/EDS)
Reduced daily sperm
production
Apoptosis of olfactory bulb
neurons
[124]
Carbon based NM
Fullerenes Rat 2 IV 0.3mg/kg GD 15 to
PND 8
Placenta (2%)
Embryo (0.9%)
(Scintillation counter)
NE [60]
Fullerenes Mouse <100 IV Not speciﬁed 8 Placenta and yolk sac
(Plasmid DNA content)
NE [156]
Fullerenes Mouse 143 IV 0.8mg/mouse 16 NE None [64]
SWCNT
(oxydized)
Mouse
200–400
IV 0.1–30g/mouse 5.5 NE Fetal morphological
abnormalities
[76]
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with an unexposed male, gene expression in the newborn females
[9,93] involved changes in gene expression relating to retinoic acid.
Retinoic acid is important in the formation of the primordial fol-
licles, thus changes can potentially disrupt the development of
germinal epithelial cells. Retinoic acid furthermore inhibits tran-
scription of the follicle stimulating hormone receptor gene and has
been shown to induce teratogenic effects on the development of
fetal reproductive organs in mice [125,126].
An additional study, with oral exposure, examined maternally
mediated toxicity of ZnO NPs in rats. Mothers were exposed daily
via oral gavage to 500mg/kg ZnO NPs starting 2 weeks prior to
mating and continuing until postnatal day 4. Exposure reduced
the number of born/live pups and their body weights, whereas
histopathological examination of offspring ovaries, testes and epi-
didymis revealed no abnormal ﬁndings [127].
A body of evidence links health effects in the offspring to DEP
exposure via the mother. Maternally mediated reproductive out-
comes include effects on fetal testis and ovary development as
well as longer term consequences such as impairment of sper-
matogenesis or altered endocrine levels in adulthood (reviewed
in [20]). As an example, Li et al. assessed the reproductive function
of male offspring on PND 28, after maternal exposure to clean air,
ﬁltered DE or nanoparticle-rich DE [109]. The relative weights of
the seminal vesicle and prostate decreased after exposure to either
diesel exposure compared with air controls, as did serum levels
of multiple serum hormones, suggesting that prenatal exposure to
particulate air pollution leads to endocrine disruption after birth
and suppresses testicular function. Because the exposure groups
had similar physiological responses, the authors conclude that in
this case the particles in DE did not speciﬁcally contribute to the
observed reproductive toxicity [109]. No indications of endocrine
disruptionwere however observed in a studywhere pregnantmice
inhaled 20mg/m3 of re-suspended nanosized DEP (SRM2975) with
a very low content of polycyclic aromatic hydrocarbons (PAHs),
or clean air for 1h/day on GD 7–19. The exposed male offspring
exhibited reduced DSP, but no differences in testicular weight or
in anogenital distance. There was also no difference in gene reg-
ulation of several testicular hormonal receptors compared to the
sham controls. This latter study therefore indicates that the parti-
cleswere involved in the reproductive effects observed in offspring
[128]. As also described for gestational and litter parameters, it is
unclear if studies of DE and DEP support ﬁndings for NP, as well
as the degree to which particle associated chemicals and exhaust
gases contribute to the observed effects.
It is apparent that there are so many different variables relative
to study design and particles in each of the studies that report pos-
itive or negative ﬁndings that an overall conclusion is difﬁcult to
make with regard to the potential hazard of NP the (male) repro-
ductive system. A key challenge in reviewing the literature is lack of
standard protocol studies, and even application of state-of-the-art
methods.
5.4. Immune system
Effects onoffspring immune function followingmaternal airway
exposure toNP during pregnancy are still incompletely studied and
comparison of existing studies is hampered due to the use of very
different study designs. Findings do indicate that NP may inter-
fere with allergy development. This is corroborated by one study
of micro-sized particles and most studies of maternal DE and PM
exposure. To our knowledge, studies of other immune diseases,
such as autoimmune responses, do not exist.
Except from one recent paper [129] and an yet unpublished
report [130], we are not aware of studies that describe mater-
nal NP exposure and the resulting adverse effects on the immune
responses in the offspring. In one animal study, female C57Bl/6
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mice were intratracheally instilled with 67g of MWCNT on the
day before mating. Starting at three weeks of age, the offspring
were sensitized and later underwent airway challenge to a model
allergen. Lower allergen-speciﬁc IgE and IgG1 responses in serum,
but higher inﬂammatory cell levels in lung ﬂuid were observed
in exposed compared to control offspring. Tolerance development
wasnotaffected [130]. El-Sayedetal. administered95g/kgcarbon
black particles to pregnant ICR mice by intratracheal instillation at
GD 9 and 15. Thymocyte and splenocyte populations were pheno-
typed at PND 5 in male offspring. Offspring from exposed dams
had higher total cell counts also leading to signiﬁcantly increased
numbers of the investigated cell populations. mRNA levels of
genes related to induction of peripheral tolerance were upregu-
lated in spleen [129]. In a similar study using microsized particles
(≈1m), BALB/c mice received a single 50g intranasal dose of
TiO2, DE or carbon black particle exposure on GD 14. After birth,
the offspring were sensitized and airway challenged with allergen.
Offspring ofmothers exposed toparticles developed airway allergy,
evidenced by allergic inﬂammation and airway hyper responsive-
ness, which was absent in control offspring [131]. The effect of
maternal TiO2 exposure was ascribed to impaired clearance of par-
ticles by macrophages and thus a greater inﬂammatory response
in the dams [132]. The latter ﬁnding indicates that “inert” parti-
clesmay become inﬂammogenic in pregnancy, due to alterations in
hormonal balance that subsequently changes regulation of uptake
of particles by alveolar macrophages and thus lessens clearance of
particles from the maternal lungs.
Maternal gestational exposure to particles in the form of DE,
DEP or PM and effects on the offspring adaptive immune response
has been studied in several rodent models. Offspring exposed to
DE and sensitized to an allergen often showed changes in allergen-
speciﬁc outcomes indicative of a more “allergic” phenotype, such
as speciﬁc IgE, lymphocyte cytokine secretion, airway inﬂamma-
tion and hyper responsiveness, [104,131,133]. The opposite [134]
or no effects on general immune function [135] have however also
been reported. In naïve (non-sensitized) offspring, maternal PM
exposure modulated T-helper type cell (Th) immune responses,
so that Th2 responses were exaggerated and Th1 responses were
suppressed [136]. Maternal PM exposure also aggravated offspring
airway inﬂammation and induced hyper responsiveness to airway
challenge by inhalation of ozone [137,138].
As also noted above, PM is a proxy for the particulate content
in DE, tobacco and wood smoke, but also co-varies with the con-
tent of associated chemicals such as polyaromatic hydrocarbons,
metals, and a wide range of other chemicals. This hampers the
ability to conclude directly on the correlation between maternal
particle exposure and adverse immunological outcomes in the off-
spring. Furthermore, abouthalf of the cited studies lack information
on thenumber of pregnant animals and/or thenumber of pupsused
from each litter, precluding evaluation of the potential for litter
effects (and thereby inﬂation of group size) in the analysis of out-
comes [129,131,137,138]. Further, only few dose–response studies
wereperformed [135,136] andmost studies reliedonasingleor few
maternal lung/nose depositions rather than repeated inhalation
exposures. Deposition of particles directly in the airways by, e.g.,
instillation, implies a much higher dose-rate compared to inhala-
tion. The route, manner of administration, timing of immunization
as well as choice of allergen and dose may be highly decisive for
the allergic phenotype [139]. The studies reporting protection from
allergy [134] or no effect on general immune function [135] were
based on maternal DE inhalation and the use of antigens very dif-
ferent from the majority of studies that used the model allergen
of chicken egg albumin. One study with maternal carbon nanotube
instillation [130] and one with DE inhalation [134] both showed
antibody suppression in offspring in contrast to the majority of
studies demonstrating development of a more allergic phenotype,
however antibodymeasurementswere not always included. Again,
modeof offspring immunization, choice of particles anddifferences
in maternal exposures may explain such observations.
5.5. Metabolic system
Metabolic function has not been studied for engineered nano-
materials, and only little information is available relative to
prenatal exposure to DEP. Gene expressionwas howevermeasured
in livers from newborn offspring from mothers exposed to carbon
black NP by intratracheal instillation and TiO2 NP by inhalation
[93,95], as described above. For carbon black, several genes and
biological pathways were differentially expressed in exposed off-
spring, hereof some with relation to metabolic function (cellular
signaling, inﬂammation, cell cycle and lipid metabolism) in female
offspring. In males, subtle changes were observed in genes related
to metabolism [95]. For TiO2 much fewer genes were differentially
expressed, and only very slight indication of effects on metabolic
function was observed [93].
Some additional information is available from a study on DE.
Pregnant mice were exposed to 2.0mg/m3 of DE (i.e., PM and gases
including O2, CO, NO and NO2, and SO2) in whole body exposure
chambers for 4h per day, GD 9–17. Exposure reduced birth weight,
but as adults the male offspring were heavier and displayed higher
non-fasting plasma insulin concentrations. These effects were not
observed in females. When fed a high-fat diet, no differential effect
on exposed males was observed, whereas the exposed female off-
spring gained much more weight than female offspring from sham
exposedmothers [120]. As discussed in Section5.1, some chemicals
associated with diesel exhaust and particles have been associated
with endocrine disruption, and some endocrine disrupting chemi-
cals have been proposed as to be “developmental obesogens” and
predispose individuals to increase fatmass andbecomeobese. Also,
maternal inﬂammation is proposed to interact with fetal develop-
ment of metabolic function [140]. At present, there is no evidence
ofmetabolic developmental programming byNP, but the described
changes in gene expression in newborn offspring from NP exposed
damsaswell as the emerginghypotheses ofmaternal inﬂammation
as a modulator of offspring metabolism warrants this to be studied
in more detail.
5.6. Cardiovascular system
Althoughvery little studied, the reportedﬁndings are suggestive
of a potential for in utero particulate exposure to affect develop-
ment of the cardiovascular system adversely.
Inhalation of 11mg/m3 TiO2 NP during pregnancy, 5h a day, for
an average of 8 days, abolished the endothelium-dependent reac-
tivity of vessels in the offspring. Together with a lack of response to
nitric oxide, theseﬁndings indicate that exposure compromised the
normal microvascular dilation in fetal vasculature [141]. Further
studies demonstrated that microvascular dysfunction coincided
with a reduction in the maximal mitochondrial respiration in both
cardiac and uterine tissues [142]. These results indicate that pre-
natal NM exposure impairs microvascular function in the offspring
and may persist through multiple developmental stages.
One report describes increased expression of Collagen type
VIIIa1 (Col8a1) in the tubular cells in the kidneys of 12 (but not 3)
weeksoldoffspringofmice instilled intranasally onGD5and9with
a total of 100gof carbonblackNM[143]. Although indices of renal
function did not differ between exposed and control offspring, this
observationmay be interpreted as a sign of tubulo-interstitial renal
ﬁbrosis, which might pose a risk for development of hypertension
later in life.
Further evidence may be gathered from studies of an atmo-
sphere of air pollution. Gestational and/or postnatal exposure of
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mice for up to 3months after birth to SaoPauloﬁlteredor unﬁltered
urban air (PM2.5: 2.9±3.0g/m3 and 16.9±8.3g/m3, respec-
tively) was associated with increased lipid peroxidation in the
hearts of the exposed offspring in adulthood [144]. Mice exposed
to ﬁltered or non-ﬁltered air at PM2.5 concentrations of 300g/m3,
6h per day, 5 days/week, during pregnancy or in the early post-
natal period had increased susceptibility to develop heart failure
induced by pressure-overload [145]. A similar exposure applied
only throughout pregnancy affected only young adult male mice,
exhibiting increased body weight, reduced blood pressure without
change in basal cardiac function, and ahigher susceptibility toheart
failure than controls [99]. More recently, it was shown in mice that
daily exposure during gestation and until weaning to ambient air
particles at a concentration of 51.69g/m3, 6h/day, 7 days a week
induced persistent cardiac dysfunction in the adult offspring [146].
Most of the described experiments have focused on maternal
exposure to airborne ambient pollution, for which the differential
effects of theparticulate fractionandchemicals components cannot
be directly inferred. Although cautiousness is called for in interpre-
tation of the ﬁndings, the potential for engineered NP to interfere
with cardiovascular development ought to be investigated.
5.7. Genotoxicity and mutations in somatic and germline tissues
Prenatal exposure to carbon black NP by inhalation (but not
instillation) has been shown to induce increased levels of DNA
strand breaks in offspring livers,whereas prenatal exposure to TiO2
NP at the same dose and to resuspended DEP (NIST2975) at half
the dose did not. Prenatal exposure to carbon black NP, TiO2 NP
and DEP NIST2975 had no effect on microsatellite instability of the
female germline, whereas prenatal exposure to DEP NIST2975 lead
to increased microsatellite instability of the male germline. The
potential effects of NP exposure on the male germline have yet to
be assessed.
The genetic material in fetuses consists of DNA in somatic tis-
sues, which originates from the father and the mother, and DNA
in the germline cells, which are established at early stages during
fetal development. Some studies have investigated DNA damage
in offspring somatic tissue (liver) following maternal pulmonary
exposure to NP by use of the comet assay for detection of DNA
strand break levels. The liver was chosen as target because the fetal
liver receives a major portion of the blood after nutrient exchange
at the placenta, and because pulmonary exposure to carbon NP
has been shown to induce DNA damage in liver tissue of adult
mice [10,147]. Neither maternal gestational exposure by inhala-
tion to TiO2 NP nor the DEP NIST 2975 increased DNA strand break
levels in offspring livers at PND 2 (and 22 for TiO2) [19,93]. Mater-
nal inhalation of carbon black NM induced increased DNA strand
breaks in liver tissue from 22 and 50 days old offspring, but not
from 2 day old offspring. The lack of signiﬁcance at GD 2 might
be due to a consistently observed high background level of DNA
strand breaks due to the sudden increase in fetal O2 levels at birth
[10]. Interestingly,whendamswere exposed to carbonblackNMby
intratracheal instillation during pregnancy (as opposed to inhala-
tion), no increase in DNA strand breaks was observed at any age (2,
22, and 50 days). Thus, only maternal exposure to carbon black by
inhalation increased DNA strand breaks in offspring livers at PND
22 and 50. The inhalation exposure was by whole-body exposure,
and therefore theoral exposure of thepregnant dams is likely larger
during inhalation exposure due to licking of the fur [10].
Germline cellsmay also be vulnerable to genetic damage.Muta-
tions in the germline can be studied by means of microsatellite
instability of expanded simple tandem repeat (ESTR) loci in mice
[148], to detect large deletions and insertions at these speciﬁc loci
in the DNA. This is possible because mice exhibit high spontaneous
mutation rates in the ESTR loci [149]. The oocyte, i.e., the female
germline, has been regarded rather resistant to the action of geno-
toxins, when exposure occurs in adulthood [150]. This might also
be the case when exposure takes place during fetal life. Indeed,
microsatellites of the female germline cells were unaffected fol-
lowing maternal gestational airway exposure in the studies of
TiO2 and carbon black NP in the studies described in more detail
above, as well as after maternal inhalation of standard material
diesel exhaust particle NIST2975 (which contains low levels of
PAHs) [149,151,152]. In contrast, male offspring whose mothers
inhaled the diesel exhaust particle of NIST2975displayed increased
microsatellite instability, indicating that the effect was induced
in utero. The effect of the prenatal exposure to DEP was perma-
nent, asmicrosatellite instabilitywerepresent in theadult offspring
months after exposure was terminated [152]. The susceptibility of
male germ cells to insult by particle exposure is supported by stud-
ies in adult mice. When adult mice were exposed to air pollution
downwind from a steel mill, male mice had signiﬁcantly increased
levels of microsatellite instability as well as increased levels of
DNA strand breaks in germ cells, whereas the increase was statisti-
cally insigniﬁcant in femalemice [153,154]. Interestingly, testicular
DNA was hypermethylated in exposed compared to control mice
exposed to ﬁltered air [153]. Absence of bulky DNA adducts and the
presence of hypermethylated DNA in testes suggest that the effect
is likely mediated by more indirect mechanisms such as systemic
circulation of inﬂammatorymediators rather than circulating PAHs
from the particles [153]. In contrast to mutations induced in male
offspring during fetal life, mutations induced in adult male mice in
adulthood seem to be transient. Thus,microsatellite instabilitywas
detected 6 weeks after exposure of the adult male mice, but not 3
or 10 weeks post-exposure [153]. The effect of prenatal exposure
to NP on the male germline has not yet been studied to the best
of our knowledge. However, if the underlying mechanism involves
systemic inﬂammation rather than particle-associated chemicals,
prenatal exposure to NP could potentially induce microsatellite
instability in the germline of male offspring.
6. Developmental effects of NP using systemic routes of
administration
The possibility that exposure to NP during pregnancy could lead
to adverse health effects on the embryohas been investigated using
also other routes of exposure than inhalation. Table 5 provides a
summary of these studies, investigating the relationship between
NP exposure during pregnancy and biodistribution and toxicity to
embryonic and extra-embryonic tissues. IV exposure is the most
commonly used route of exposure in exploration of the ability of
different types of NP to reach the placenta and the fetus and/or
induce placental and fetal morphological alterations. This route is
obviously not representative for environmental and occupational
scenarios,where inhalation is theprimary routeof exposure. It does
howeverallowforevaluationof thepotential fordirect effectsof the
administeredmaterial, since it bypasses translocationover the lung
barrier at the port of entry in inhalation. As a result, the relationship
between the administered doses and the corresponding effects can
be estimated.
With very few exceptions, the available data from rodent stud-
ies indicate that systemically administered NP are able to reach the
placenta, cross the blood–placental barrier and accumulate in fetal
tissues. Although not many studies have quantiﬁed the amount
of NPs able to reach the placenta and translocate to the fetus,
the results suggest that the exposure to NP may cause adverse
health effects on the pregnant dam and fetus. Negative effects
appear to depend on chemical composition as well as several
physico-chemical characteristics, including size, shape and func-
tionalization.
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Among metal based NPs, gold NP administered to mice have
been shown to reach theplacenta and translocate to the fetus.Over-
all, translocation seems to depend onNP size and functionalization,
as well as gestational stage and inﬂammatory status of the uterus
[47,65,70], clearly indicating that several factors inﬂuence the abil-
ity of NPs to cross the blood–placental barrier. Gold NPs, although
able to distribute in embryonic and extra-embryonic tissues, do
not seem to adversely affect embryonic development, even at the
highest dose of 7.2g Au/g body weight [47]. This ﬁnding appears
to be mirrored for silver NPs. When silver NP were administered
at GD 9.5, i.e., prior to formation of the placental barrier in the
mouse, silver was detected in the extra-embryonic tissues (mainly
the yolk sac) and only in very lowamounts in the embryo (0.008%of
the administered dose). No interference with proper development
was observed [155], but morphological analysis of the embryo was
performed at GD 10, when organogenesis is far from complete.
In contrast, intravenous administrationof 35nmTiO2 and70nm
SiO2 NP in late gestation, was associated with in utero growth
restriction and increased rates of fetal resorption [64] at the very
high dose levels of 1.6mg/mouse, administered as two separate
dosesof 0.8mg/mouseatGD16and17, respectively.When reduced
by half no effects were observed, suggesting that these NP repre-
sent a risk for pregnancy only in the case of massive exposure at a
high dose rate. The dose of the administered material may there-
fore be a key point in mediation of NP developmental toxicity. It
could be speculated that the adverse effects might originate from
accumulation of NPs (and/or ions released from the particles) in the
placenta that subsequently inducedvasculardysfunction, andaccu-
mulation in embryonic tissues,where theymayphysically interfere
with developmental mechanisms. Carbon based NP, systemically
administered, are also able to distribute to the placenta and yolk
sac and partly translocate to the fetus. This is true for fullerenes
of different sizes, administered either before placentation is ini-
tiated [156], or later in gestation [60]. Interestingly, even at very
high doses (0.8mg/mouse), at which other NPs induce severe fetal
effects, fullerenes were non-toxic [62]. In comparison, SWCNT and
MWCNT interfere with placental and embryonic morphogenesis
in a size, concentration and functionalization dependent manner
[61,76,157,158]. Intravenously injected short SWCNT have been
shown to induce a wide range of morphological alterations to
embryosat concentrationsas lowas100ng/mouse.While function-
alization of SWCNT with COOH groups exacerbates embryotoxicity
[76], the introduction of polyethylenglycol chains strongly reduces
this effect [157,158]. The diameter also appears an important
mediating factor in embryotoxicity, at least for MWCNTs. Thus,
IV administered MWCNT accumulated in the placenta, irrespec-
tive of diameter (outer diameter >8, 20–30 and 50nm) but only
induced fetal growth restriction, brain malformations and reduced
pup survival when the outer diameter was large (50nm) [158].
The use of NP in consumer products, such as cosmetics and food,
requires assessment of developmental toxicity after oral and der-
mal administration. While studies using dermal application are
lacking, a few studies have investigated the effect of acute and
chronic exposure to NP after oral administration. After a single
administration during organogenesis (GD 9), Ag NPs reached the
fetal liver and kidney, as evaluated by TEM. At the lowest dose
(10mg/kg), fetal viability was signiﬁcantly reduced, while at much
higher concentrations (100 and 1000mg/kg) no adverse effects on
both dams and fetuses were observed [159]. These results appear
in line with what was observed by Mwilu et al. [160]. Ag NPs
exposed to simulated stomach ﬂuid aggregated and also released
ionic silver, which in turn associatedwith aggregates as silver chlo-
ride. It could be then speculated that at high concentrations Ag
NP agglomerated in the stomach, and thereby reduced absorp-
tion and increased clearance. In this same study, the effect of oral
administration of TiO2 was also evaluated. Differently from what
observed for Ag, adverse effects of TiO2 were observed only at
the highest concentrations of 100 and 1000mg/kg [159], suggest-
ing that agglomeration did not occur for these NP. Similar results
were obtained in parallel studies using SWCNTs [161]. Interest-
ingly, chronic oral administration of small Ag NPs (8nm) to rats
before and throughout gestation was not associated with toxic
effects [162], while chronic administration of ZnO NP (500mg/kg)
induced fetal resorptions and reduced the number of live pups
[115].
Very few studies have evaluated the effect of NP after intraperi-
toneal and subcutaneous injection; the reason probably resides
in the low signiﬁcance of these two routes for risk assessment of
human exposure to NM. After intraperitoneal injection, gold NP (2
and 40nm) were not detected in either the placenta or the fetus
[163], whereas fullerenes (of non-speciﬁed size) distributed not
only to the yolk sac and embryos, but also induced severe mor-
phological abnormalities [164].
7. Support from epidemiological studies
At present there are no sound epidemiological studies that have
assessed the developmental toxicity of NM. This section therefore
focuses on unintentionally produced particles such as particulate
matter (PM) generated from automotive, industrial and house-
hold emissions. Most of the evidence is accumulated from 1999
onwards. The research ﬁeld is, just like for animal research on
NP effects, rapidly expanding, and the literature published so far
needs to be interpreted with caution. Assessment of air pollution
exposure (including outdoor and indoor levels) duringpregnancy is
challenging. In addition, other environmental factorsmay correlate
with air levels of particulate matter, e.g., noise [165] and meteo-
rological factors, which may inﬂuence speciﬁc birth outcomes on
their own and act as confounders.
The largest body of evidence relates to the associations between
maternal exposure to PM and effects on birth weight (corrected
for gestational age). In a meta-analysis of studies in 14 centers, an
increase by 10g/m3 in PM10 concentration was associated with
a decrease of 9 g (95% conﬁdence interval, 5; 13) in mean birth
weight adjusted for gestational duration and other covariates, and
an odds-ratio of 1.02 in risk for term low birth weight (95% con-
ﬁdence interval, 1.01–1.04) [166]. By use of land-use regression
models in urban areas, the association between maternal exposure
and low birth weight at term was stronger [166]. Associations of
PM levels with head circumference have also been reported [166].
Thus, the evidence regarding PM effects on birth weight-related
outcomes can be seen as strong.
There is intermediate to strong evidence for an effect of mater-
nal inhalation of PM and other atmospheric pollutants on the
risk of preeclampsia, a pregnancy complication characterized by
maternal hypertension in conjunction with excretion of protein in
urine,whichconstitutes amajor causeofpretermdelivery (recently
reviewed in [167]. Association with the risk of premature rupture
of membranes is also plausible [168]. Many studies have linked PM
exposure to the risk of preterm delivery (i.e., before 37 gestational
weeks). Although formal meta-analyses are lacking, the evidence
appears less consistent than for birth weight.
Effects on the occurrence of congenital malformations are, gen-
erally, challenging to study in humans [169]. Currently, there is
strongest evidence regarding maternal exposure to PM and other
atmospheric pollutants for cardiac congenital malformations such
as atrial septal defects [170]. Amore recentmeta-analysis observed
signiﬁcant associations only between NO2 concentrations (and not
particles) in air and coarctation of the aorta [171].
The placenta has been little studied relative to PM in humans so
far [172–174]. In theGeneration R cohort in Rotterdam, PM10 levels
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in the 2 months prior to delivery were associated with a decrease
in placental weight, and a proportionally similar decrease in birth
weight, i.e. the placental to fetal weight ratio was not associated
with PM10. At delivery, PM10 pregnancy averages were also associ-
ated changes in some markers of placental function, i.e., increased
fetal soluble fms-like tyrosine kinase 1 (sFlt-1) and decreased fetal
(but not maternal) placental growth factor (PIGF). This was inter-
preted by the authors as being consistent with PM10 inducing
an anti-angiogenic state. PM10 levels were also associated with a
decreased pulsatility index in the umbilical artery, as assessed by
second-trimester Doppler measurements [173].
Regarding immunological function at birth, a few studies have
suggested that air pollution levels during pregnancy could be asso-
ciated with changes in immunological markers assayed in cord
blood, such as CD4+CD25% T-cell percentage [175], as well as B-
lymphocyte fraction [176].
More recent studies have also reported association between
pregnancy air pollution levels and child health parameters, such
as respiratory health or neurodevelopment [177–179]. Some stud-
ies show that children exposed to air pollution in utero exhibit
increased risk of diabetes, obesity or cardiovascular disorders
[180–182]. Air pollution has been proposed as a new paradigm
in the origin of metabolic disorders. At this stage, it is too early
to ﬁrmly conclude that such associations are driven by pregnancy
exposures, and not childhood (postnatal) exposures, which gener-
ally correlate with prenatal exposures.
8. Discussion
The nanomaterial industry is growing rapidly and with it, appli-
cation of NMs in consumer products. This increases the risk for
exposure of pregnant women and thus the concern that mater-
nal inhalation of airborne NP may adversely interfere with fetal
and childhood development. This concern originates in part from
epidemiological and experimental studies of ambient air pollution,
which may contain considerable levels of particles. Although, dif-
ferential effects of the particulate fraction versus other chemical
and gaseous components of polluted air cannot be directly inferred
from these studies and caution is needed in their interpretation
with respect to the role of nanosized particles, their ﬁndings justi-
ﬁes a thorough assessment of the implications ofmanufacturedNM
exposure for possible adverse health outcomes following exposure
early in life.
Overall, the scientiﬁc literature available to date, as summarized
in this paper, indicates that current knowledge about the possible
health risks of exposure to NP is very limited for reproductive and
developmental outcomes. Systemically administered NP seem able
to reach the placenta, cross the blood–placental barrier, accumu-
late in fetal tissues and cause adverse health effects on the pregnant
dam and fetus. The limited data set on airway exposure to NP does
however not indicate adverse effects on the classical gestational
and litter parameters. Even if adverse effects of maternal exposure
to NP may not be apparent in the embryo/fetus, they may manifest
later in life. Thus several studies in the limitedstudydatabase report
that offspring organ functionmay be susceptible to perturbation by
maternal inhalation exposure. This concerns the male reproduc-
tive, nervous, immune, and cardiovascular systems, of which the
latter three are rarely subject to study in guideline studies. Female
reproductive and metabolic function has hardly been studied.
Of note, in one study female mice were instilled with MWCNT
prior to conception, at a dose level thatwouldbe expected to induce
maternal lung inﬂammation that lasted throughout gestation. Cen-
tral nervous and male reproductive function was not affected by
this exposure [96], but a change in immune function was observed
[130]. This could indicate that the immune system ismore sensitive
tomaternal chronic inﬂammation thanmale reproductive function
and the investigated domains of central nervous system function.
The ﬁndings on NP are generally corroborated by observations
in studies of air pollution, primarily from diesel engines, and DEP.
It should however be noted that in contrast to ﬁndings for NP, sev-
eral studies of DE and DEP observe that maternal inhalation hereof
affects offspring weight, at birth, in lactation, and even in adult-
hood. Possibly, these effects do not owe to the particulate fraction
in polluted air, but rather to associated chemicals, such as PAHs.
Studies in experimental animals offer several advantages, such
as testing under controlled conditions, thereby precluding con-
founding factors that may occur in human studies of ambient air
or diesel engine exhaust, as well as testing of NM prior to intro-
duction in commercial products. The use of animal models in the
study of developmental effects may be somewhat hampered by
difference in placental structure between species. Ideally, model
species should compare to humans and possess a hemochorial pla-
centa, where the maternal blood is directly in contact with fetal
trophoblastic tissue [48]. Mice and rats are the most used model
animals in toxicology, and possess this type of placentation. Espe-
cially mice reach the deﬁnitive placental structure relatively later
than humans, and furthermore have a much less invasive tro-
phoblast [53]. In comparison, rabbits and guinea-pigs appear to be
more similar to humans [183,184], and might therefore be prefer-
able animal models in this respect. Early embryogenesis occurs
before placentation is completed and studies of exposures early
in pregnancy would therefore be expected to be little inﬂuenced
by interspecies differences in placentation. When interpreting and
designing animal studies for translation to human health, the
longer gestation time in humans compared tomany animalmodels
(270 vs 20 days in rodents) might allow NP accumulation beyond
a critical threshold for induction of direct effects in the human
embryo/fetus. Such threshold (if any) isnot currentlyknown.Deter-
mination hereof probably represents one of the major issues in the
future research on developmental toxicity. In this light, pulmonary
exposure of pregnant animals with a gestation time comparable to
that of humans might be of great help.
8.1. Testing strategy
A general tiered testing strategy for safety evaluations of NM
was proposed by an expert working group of the International Life
Sciences Institute (ILSI) Research Foundation/Risk Science Institute
[185], presented at ECETOC’s Workshop on testing strategies to
establish the safety of NM. The ﬁrst tier of this proposed screening
strategy comprises short-term inhalation studies, and no speciﬁc
developmental and reproductive toxicity studies. Potential effects
on the reproductive system, placenta, and fetus are included in
the second tier of the proposed screening strategy, recommen-
ding the use of protocols similar to the OECD Guideline 422
[26] (Combined Repeated Dose Toxicity Study with the Reproduc-
tion/Developmental Toxicity Screening Test) [185].
It is not explicitly mentioned which outcomes from the ﬁrst tier
studies would trigger initiation of second tier studies. The work-
ing group warned that potential oxidative stress and inﬂammatory
responses elicited by NP in the respiratory tract may lead to release
of mediators which may subsequently lead to indirect (secondary)
effects in extra-pulmonary organ systems. If this is indeed the case,
it could be argued that the observation of release of inﬂammatory
mediators in acute and sub-acute inhalation studies in the ﬁrst tier
would trigger repeated dose toxicity studies that investigate the
effects of nanomaterial exposure on reproductive organs and the
developing fetus. This is all the more relevant, as both reproduc-
tive function and fetal development is indeed sensitive to oxidative
stress and inﬂammation [8,12,13,82,83].
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A testing strategy proposed by theOECDWorking Party onMan-
ufactured Nanomaterials suggests that if reliable local, short-term
and repeated dose toxicity studies do not indicate any biological
effects and translocation, then systemic effects can be considered
unlikely and further testing such as reproductive and developmen-
tal testing may not be necessary [6], while others are in favor of
addressingdevelopmentalneurotoxicity asearly as at the screening
stage [5]. In the adult, lung inﬂammationhasbeen shown to subside
with time for many NMs [186]. Persistent effects may therefore be
less likely. In the fetus these transient events may however induce
persistent effects, i.e.,what is a temporaryphenomenon in theadult
may have lifelong consequences for organ function in the offspring.
Absence of translocation of particles to the systemic circulation
ought therefore not to exclude developmental toxicity testing per
se
As far as exposure routes other than inhalation are concerned, it
is worth noting the work by Hong et al., who published a reproduc-
tive and developmental toxicity study on silver NP in rats according
to the OECD test guideline TG422 Combined Repeated Dose Tox-
icity Study with Reproduction/Developmental Toxicity Screening
Test [26,162]. This guideline recommends oral administration of
NP to both dams and sires from 14 days premating until 54 days
postpartum at a dose range of 0–250mg/kg. Although the pater-
nal and maternal reproductive organs were examined, the major
failure of following the TG was that it did not require examina-
tion of reproductive organs in the offspring, thus allowing for no
conclusions to be drawn on the reproductive health of F1 animals
following maternal NP exposure. The authors reported no signif-
icant changes in mating, fertility and pregnancy rates, nor any
toxicity to pups even at the highest dose of 250mg/kg [162]. It
should be considered that the lack of toxicity may be related to
poor bioavailability, as Loeschner et al. demonstrated orally admin-
istered silver NPswere excreted into feces after oral administration
with little being absorbed [187]. This highlights the importance
of selecting the most relevant exposure route and understand-
ing the subsequent ADME proﬁle in determining the true impact
of parentally mediated exposure to NP. Whilst evidence to date
suggests a growing interest in trying to understand the potential
impact of maternal exposure on the health of the offspring, there
is a strong call for comprehensive and harmonized assessment of
both endocrine and reproductive effects in the safety evaluation
of NM. Although sparse, the published studies on developmen-
tal toxicity of NP indicate that gestational and litter parameters
are less of a concern than changes in offspring postnatal organ
function. Some guidelines include functional testing of the off-
spring. Thus, offspring male reproductive parameters are included
in generation guidelines (TG416 Two-Generation Reproduction
Toxicity Study, TG443 ExtendedOneGeneration Reproductive Tox-
icity Study) [188,189]. Offspring neurofunction is described in TG
426 Developmental Neurotoxicity Study [190], and although it is
not often used [191], it exists. Immune function undergoes some
testing in the TG443 ExtendedOneGeneration Reproductive Toxic-
ity Study [189], but this does not include evaluation of the potential
for increased propensity to develop allergy, as observed in several
studies of maternal exposure to particles. No protocols exist for
studyof developmental effects on the cardiovascular andmetabolic
systems.
More recently, the International Organization for Standardiza-
tion (ISO) released a compilation of methods intended to aid the
process of toxicological screening of engineered and manufactured
NMprior to full-scale toxicological testing, analysis, and risk assess-
ment. For developmental toxicity, the report states that ex vivo
humanplacental perfusionmodels haveprovenuseful in determin-
ing whether small molecules and NP are able to cross the placental
barrier. This method can therefore help ascertain whether a given
nanoparticlemightput adeveloping fetus at risk [192]. Thismethod
is however only relevant in screening for the potential for direct
effects on fetal development. Furthermore, placentas for use in the
ex vivo human placental perfusion model are only available for
study at the ﬁnal stage of development of this organ and cannot be
applied as a standardmethod, as placentas are not readily available.
Asemphasizedabove, thepermeabilityof theplacenta changesdra-
matically during pregnancy, and therefore little information can
be gained by the ex vivo model on earlier stages of gestation. As
described, there is increasing evidence that the placenta might be
affected byNP. Addition of viability and inﬂammatorymeasures for
the exposed placental tissue might provide important information.
Furthermore, the embryonic stem cell test, rat limb bud test, and
micromass test are suggested as partial replacements for in vivo
developmental toxicity tests [192]. At present the applicability of
these tests in nanoparticle reproductive toxicity needs to be estab-
lished. The embryonic zebraﬁsh model can be employed to rapidly
provide information on the potential of nanomaterials ability to
perturb embryonic development,manifested as death,morpholog-
ical malformations or behavioral abnormalities. It should however
be taken into account, that this model does not include a placenta
and will therefore only be of use for the study of direct effects of
NP, particularly regarding development and reproduction.
Combining the current knowledge and recommendations by
various groups of experts reviewed above, it is clear that this area
of nanotoxicology is very much in its infancy. Signiﬁcant data
gaps exist as to placental and embryo–fetal exposure as well for
the potential for embryo–fetal toxicity, following maternal inhala-
tion exposure to NP in pregnancy. In order to advance the ﬁeld,
we recommend making optimal use of the available models and
assays, in assessment of critical aspects of toxicological hazard
of NM (see Section 8.1.2 Recommendations for research). Impor-
tantly, attention should be given to the advantages and limitations
of each availablemodel. This approachwill be able to supply insight
into critical aspects of study design that can be employed for
dedicated studies in experimental animals in order to support a
well-underpinned human risk assessment of nanoparticle expo-
sures. In the future, it shouldbe considered to combine theavailable
models in an integrated testing strategy.
8.1.1. Recommendations for components of a testing strategy
Clearly, a testing strategy for NP should be established, consid-
ering the increased production and application of nanomaterials.
To suggest a speciﬁc testing strategy based on the sparse, current
level of knowledge implies a risk of overlooking important aspects,
as signiﬁcant groundwork is still required. Some recommendations
may however be deduced from the above review and discussion:
- Pregnancy and fetal development are sensitive to perturbation by
inﬂammation, therefore particle induced inﬂammation may be
a potential mediator of developmental toxicity. Systemic effects
may thereforebe likely even if particlesdonot seemto translocate
from the lungs to the maternal systemic circulation. The obser-
vation of release of inﬂammatory mediators in ﬁrst tier studies
could potentially serve as a trigger for study of developmental
toxicity.
- Changes in offspring organ function, such as effects on the male
reproductive, immune, cardiovascular and neurological systems
may be more of a concern than effects on gestational and lit-
ter parameters. Findings in a few studies furthermore indicate
that also metabolic function and the ability to induce mutations
in the male germ line is worth addressing. Of note, reproduc-
tive function in female offspring remains to be studied. Although
guidelines may not have developed to guide experimental design
for study of all relevant organ systems, functional testing ought
to be an important priority in developmental toxicity testing of
NP.
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- The ex vivo human placental perfusion models may be useful in
determining whether NP are able to cross the placental barrier,
and thereby in screening for the potential for direct effects of
NP on fetal development as well as for placental effects, in late
pregnancy.
- Some in vitro tests might be useful in reproductive toxicity test-
ing, but the applicability nanoparticle reproductive toxicity needs
to be established. The embryonic zebraﬁsh model may be of use
for the study of direct effects of NP.
- Studies ought to design exposure to best mimic that of humans
with respect to relevant speciesofparticles, exposure route, levels
and concentrations and duration, to be applied at relevant stages
of pregnancy.
8.2. Speciﬁc research questions
To ﬁll signiﬁcant data gaps and provide a sound basis for devel-
opment of a general testing strategy, several lines of research
ought to be pursued. Importantly, state-of-the-art-methods must
be applied. The level of knowledge thatmay be extracted fromeach
study might increase if nano-toxicologists and reproductive sci-
entists work more closely together in designing and interpreting
studies, to achieve the optimal design for investigation of speciﬁc
hypotheses and increase the understanding of, e.g., subtle changes
in hormone regulation and developmental pathways that may lead
to long term reproductive health concerns in the life after birth.
Among others, the study of dose-effect is highly warranted.
One of the most relevant questions relate to NP-induced lung
and systemic inﬂammation. Is inﬂammation the driving force for
developmental effects? And does the inﬂammatory response differ
between the pregnant and the non-pregnant state? If pregnancy
enhances the inﬂammogenic potential of NP and inﬂammation is
the driving force for developmental effects, this may imply that
pregnant women will need a higher degree of protection than pre-
dicted from non-pregnant models. Along the same line of thinking,
it might be important to know how the developmental trajec-
tory is affected if exposure to NP occurs on top of existing states
of low-grade chronic inﬂammation, encountered in for example
asthma and obesity, compared to exposure in a non-inﬂammatory
state. This is especially important because inﬂammation seems to
enhance transfer of particles across the placenta [70].
There are some indications that the placenta may play a central
role in themediationof developmental toxicityNP, but this remains
to be studied for administration of particles via the airways, as does
translocation of particles across the placenta.
To enable grouping of particles for risk assessment, it seemsper-
tinent to study patterns of effect for different NP. This would imply
the use of comparable study designs with respect to exposure regi-
mens, and outcome assessment. A partial step would be to apply
accepted guidelines, e.g., from the OECD or EPA as has been sug-
gested for developmental neurotoxicity [5]. This might also help
delineating the relative contribution of particles compared to asso-
ciated chemicals for ambient air pollution particles.
The review identiﬁes several organ systems to be potentially
sensitive to maternal inhalation of particles during pregnancy. It is
obviously not feasible to study all for a larger number of particles.
One point for departure could therefore be to identify the organ
systems and speciﬁc outcomes that may be most sensitive to per-
turbationbydevelopmental exposure to particles. These could then
be studied for a larger number of particles.
Many of the described studies use intratracheal instillation to
deliver the NP. This does however imply a high dose rate. It seems
highly warranted to describe the importance of dose rate and the
potential underlying differences for induction of inﬂammation and,
potentially, translocation of particles across the lung and placenta.
9. Conclusion
The available published data are as yet too limited for deﬁni-
tive conclusions. Although the available database on NP describes
several organ systems in the offspring to be potentially sensi-
tive to maternal inhalation of particles, large uncertainties exist
about the implications of such exposures for embryo–fetal devel-
opment as well as for possible long term health effects later in
life. Importantly, indirect adverse developmental effectsmay occur
secondarily to maternal inﬂammatory responses. Epidemiologi-
cal studies available to date have shown associations between
exposure to particles as they occur in ambient air and adverse
health effects in the offspring. These studies do however not allow
for deﬁnitive statements as to the relevance hereof for develop-
mental toxicity of NP at the present time. The emerging picture
suggests that embryo–fetal exposure to NP after exposure via
relevant routes (inhalation and oral) may be limited. However,
exposure of the conceptus has been shown to occur in experi-
mental studies and translocation from the maternal lungs to the
fetus has yet to be studied. Overall, experimental studies indi-
cate that adverse health effects of such exposures cannot be
excluded, but at present the potential for hazard has not been
characterized. We conclude that further dedicated research on
systemic exposure, toxicity mechanisms speciﬁc for particulate
matter, exposure and effect relationships, is needed. Several gaps
remains to be ﬁlled before a testing strategy for NP can be estab-
lished on a sound scientiﬁc basis. It is without doubt that a testing
strategy is needed, particularly considering the increased pro-
duction and application of nanomaterials and related consumer
products.
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